caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1982780789

Christopher Behrens

PRACTICEUNIVERSITY OF WASHINGTONSee all providers at this practice →
Family PracticeSeattle, WAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
Final MIPS score
93.8
Quality
74.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.79%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
177
Unique beneficiaries
—
Total services
277
Distinct HCPCS
5
Medicare payment
$13K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 2,681 Family Practice providers in WA — above median (cohort median 352).
REFERRAL NETWORK

Where Christopher Behrens's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
HARBORVIEW MEDICAL CENTER135923
UNIVERSITY OF WASHINGTON1892
TIMBERLAKE, DIANE1363
Amanda Kost
Family Practice · Seattle, WA
1248
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
5,758
Beneficiaries
—
Total drug cost
$4.4M
Distinct drugs
114
Brand share
43.9%
Top prescribed drugs
Bictegrav/Emtricit/Tenofov Ala428 claims
Atorvastatin Calcium412 claims
Dolutegravir Sodium299 claims
Emtricitabine/Tenofov Alafenam222 claims
Losartan Potassium183 claims